Skip to content

The Effects of Patient Features on Opioid Induced End-Tidal CO2

The Effect of Patient Features on Opioid Induced End-Tidal CO2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01371903
Acronym
Capno
Enrollment
278
Registered
2011-06-13
Start date
2010-08-31
Completion date
2012-11-30
Last updated
2014-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use During Medical Care

Keywords

morphine, fentanyl, dilaudid, opioid, capnography

Brief summary

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.

Detailed description

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.

Interventions

None listed

Sponsors

Albany Medical College
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* non intubated patients receiving intravenous opioid medications

Exclusion criteria

* mechanically ventilated patients * patients with physiologic shock

Design outcomes

Primary

MeasureTime frameDescription
end tidal carbon dioxidestudy start, 30 minutes, 60 minutes, 90 minutes, 120 minutesmeasured through small nasal cannula (plastic tube at base of nares)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026